|4Jan 28, 5:07 PM ET

Looker Benjamin 4

4 · Esperion Therapeutics, Inc. · Filed Jan 28, 2022

Insider Transaction Report

Form 4
Period: 2022-01-27
Looker Benjamin
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-27+100,450100,450 total
    Exercise: $3.65Exp: 2032-01-27Common Stock (100,450 underlying)
  • Award

    Common Stock

    2022-01-27+70,80070,800 total
Footnotes (2)
  • [F1]Such award will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of January 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.
  • [F2]Such options will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of January 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.

Documents

1 file
  • 4
    wf-form4_164340762549753.xmlPrimary

    FORM 4